(Reuters) – European shares rose on Thursday as investors awaited inflation data and minutes from the latest European Central Bank meeting, while Basilea shares jumped after U.S. regulators approved the manufacturer’s bacterial therapy.
The continent-wide index was up 0.1% as of 0720 GMT, ahead of the region’s February producer prices due at 0900 GMT.
The producer price index is likely to fall 8.6%, unchanged from January, according to economists polled by Reuters.
Later in the day, investors will review minutes from the ECB’s March meeting to determine the timing of its long-awaited first rate cut.
Shares in Basilea Pharmaceutica rose 9.4% to a more than six-month high after the Swiss firm won US health regulator approval for its antibiotic Zevtera, which treats bacterial infections, including multidrug-resistant strains.
Compugroup shares rose 7.5% after Morgan Stanley upgraded the German medical software company’s stock from “equal weight” to “outperform.”